help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Published ahead of print on August 28, 2008, doi:10.1164/rccm.200804-619OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Supplement
Right arrow All Versions of this Article:
200804-619OCv1
178/9/913    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xu, W.
Right arrow Articles by Bourbeau, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xu, W.
Right arrow Articles by Bourbeau, J.
American Journal of Respiratory and Critical Care Medicine Vol 178. pp. 913-920, (2008)
© 2008 American Thoracic Society
doi: 10.1164/rccm.200804-619OC

Original Article

Independent Effect of Depression and Anxiety on Chronic Obstructive Pulmonary Disease Exacerbations and Hospitalizations

Wanning Xu1,2, Jean-Paul Collet1,3, Stanley Shapiro1, Yingxiang Lin4, Ting Yang4, Robert W. Platt1, Chen Wang4,* and Jean Bourbeau1,2,*

1 Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Canada; 2 Respiratory Epidemiology and Clinical Research Unit, Montreal Chest Institute, McGill University Health Center, Montreal, Canada; 3 Child and Family Research Institute, Children's and Women's Health Center, Department of Pediatrics and Department of Health Care and Epidemiology, University of British Columbia, Vancouver, Canada; and 4 Beijing Institute of Respiratory Medicine, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China

Correspondence and requests for reprints should be addressed to Chen Wang, Ph.D., Beijing Institute of Respiratory Medicine, Beijing Chaoyang Hospital, No. 8, Bai Jia Zhuang Road, Chaoyang District, Beijing, China, 100020, E-mail: cyh-birm{at}263.net; and to Jean Bourbeau, M.D., Respiratory Epidemiology and Clinical Research Unit, Montreal Chest Institute, Room k1.32, 3650 St. Urbain Street, Montreal, PQ, Canada H2X 2P4, E-mail: jean.bourbeau{at}mcgill.ca

Rationale: Depression and anxiety are significant comorbid and potentially modifiable conditions in chronic obstructive pulmonary disease (COPD), but their effects on exacerbations are not clear.

Objectives: To investigate the independent effect of depression and anxiety on the risk of COPD exacerbations and hospitalizations.

Methods: A multicenter prospective cohort study in 491 patients with stable COPD in China. Multivariate Poisson and linear regression analyses were used, respectively, to estimate adjusted incidence rate ratios (IRRs) and adjusted effects on duration of events.

Measurements and Main Results: Depression and anxiety were measured using the Hospital Anxiety and Depression Scale (HADS) at baseline. Other measurements included sociodemographic, clinical, psychosocial, and treatment characteristics. Patients were then monitored monthly for 12 months to document the occurrence and characteristics of COPD exacerbations and hospitalizations. Exacerbation was determined using both symptom-based (worsening of ≥1 key symptom) and event-based definitions (≥1 symptom worsening plus ≥1 change in regular medications). A total of 876 symptom-based and 450 event-based exacerbations were recorded, among which 183 led to hospitalization. Probable depression (HADS depression score ≥ 11) was associated with an increased risk of symptom-based exacerbations (adjusted IRR, 1.51; 95% confidence interval [CI], 1.01–2.24), event-based exacerbations (adjusted IRR, 1.56; 95% CI, 1.02–2.40), and hospitalization (adjusted IRR, 1.72; 95% CI, 1.04–2.85) compared with nondepression (score ≤ 7). The duration of event-based exacerbations was 1.92 (1.04–3.54) times longer for patients with probable anxiety (HADS anxiety score ≥ 11) than those with no anxiety (score ≤ 7).

Conclusions: This study suggests a possible causal effect of depression on COPD exacerbations and hospitalizations. Further studies are warranted to confirm this finding and to test the effectiveness of antidepressants and psychotherapies on reducing exacerbations and improving health resource utilizations.

Key Words: chronic obstructive pulmonary disease • exacerbation • depression • anxiety • risk factor


AT A GLANCE COMMENTARY

Scientific Knowledge on the Subject
Depression and anxiety are significant comorbid and potentially modifiable conditions in chronic obstructive pulmonary disease, but their effects on exacerbations are not clear.

What This Study Adds to the Field
This study suggests a possible causal association between depression and chronic obstructive pulmonary disease exacerbation and hospitalization. Interventional trials appear to be warranted to evaluate the effectiveness of antidepressants and psychotherapies on reducing exacerbations.

 



This article has been cited by other articles:


Home page
 Am. J. Respir. Crit. Care Med.Home page
R. de Marco, S. Accordini, J. M. Anto, T. Gislason, J. Heinrich, C. Janson, D. Jarvis, N. Kunzli, B. Leynaert, A. Marcon, et al.
Long-Term Outcomes in Mild/Moderate Chronic Obstructive Pulmonary Disease in the European Community Respiratory Health Survey
Am. J. Respir. Crit. Care Med., November 15, 2009; 180(10): 956 - 963.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J. D Maclay, R. A Rabinovich, and W. MacNee
Update in Chronic Obstructive Pulmonary Disease 2008
Am. J. Respir. Crit. Care Med., April 1, 2009; 179(7): 533 - 541.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2008 American Thoracic Society 		  ATS 2008 State of the Art Course